Cellular Senescence Protocols are targeted clinical strategies designed to manage or eliminate senescent cells, which are dysfunctional cells that accumulate with age and secrete harmful pro-inflammatory molecules known as the SASP. Effective protocols aim to clear this cellular debris to restore healthy tissue paracrine signaling and mitigate chronic inflammation. This is a crucial intervention for optimizing tissue healthspan.
Origin
The development of these protocols stems directly from aging research identifying cellular senescence as a core mechanism contributing to age-related pathology across organ systems. Protocols often leverage compounds termed senolytics, developed to selectively target and destroy these persistent cells. The clinical translation focuses on reversing detrimental inflammatory signaling.
Mechanism
The mechanism of action for many protocols involves the introduction of senolytic agents that exploit metabolic vulnerabilities unique to senescent cells, inducing programmed cell death. Additionally, protocols may incorporate hormonal adjustments, such as optimizing DHEA or growth hormone availability, which can suppress the pro-survival signaling that keeps senescent cells active. Clearing these cells restores the local microenvironment to a healthier, less catabolic state.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.